ArticleThe role of CD58 and CD38 in evaluation of minimal residual disease in childhood B-acute lymphoblastic leukemia
ArticleThe role of CD58 and CD38 in evaluation of minimal residual disease in childhood B-acute lymphoblastic leukemia
ArticleExpression of aberrant markers in acute leukemia at South Egypt Cancer Institute: A retrospective study
ArticleExpression of aberrant markers in acute leukemia at South Egypt Cancer Institute: A retrospective study
ArticleSignificance of aberrant CD82 expression and their Clinical Impact in Acute Lymphoblastic Leukemia among Sudanese Patients in Khartoum state
ArticleSignificance of aberrant CD82 expression and their Clinical Impact in Acute Lymphoblastic Leukemia among Sudanese Patients in Khartoum state
ArticleProm-1 (Cd 133) Overexpression in Adult Acute Lymphoblastic Leukemia Egyptian Patients and Relation to Outcome
ArticleProm-1 (Cd 133) Overexpression in Adult Acute Lymphoblastic Leukemia Egyptian Patients and Relation to Outcome
ArticleLong term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute
ArticleLong term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute
ArticleImpact of the Clinicolaboratory Characteristics on the Treatment Outcome of the Pediatric Patients with Acute Lymphoblastic Leukemia at South Egypt Cancer Institute
ArticleImpact of the Clinicolaboratory Characteristics on the Treatment Outcome of the Pediatric Patients with Acute Lymphoblastic Leukemia at South Egypt Cancer Institute